IQAir has decades of experience in the field of airborne infection control; its stand-alone air purifiers have been deployed in the fight against the coronavirus ever since the first SARS outbreak in 2003 in Asia. In the fight against the COVID-19 pandemic, many tens of thousands of IQAir high-performance air cleaners have been deployed in hospitals, medical quarantine facilities, schools, and government buildings all over the globe to minimise the risk of indoor infection transmission. To this day, IQAir is the only company we know of that can provide peer-reviewed scientific evidence that its air purifiers using HyperHEPA filtration technology are able to reduce airborne infection rates (invasive aspergillosis) by more than 50% in healthcare settings.
While airborne infection control has been one of the leading applications for IQAir systems, IQAir’s actual speciality is day-to-day indoor air pollution control in the most heavily polluted places on earth. We can safely claim that no other room air purifier manufacturer has more worldwide experience in airborne pollution and infection control than the IQAir Group of Switzerland.